'Dramatic' early phase 1 results for AG-120 in IDH1 mutated AML
Results presented November 19 by University of Colorado Cancer Center investigator Daniel Pollyea, MD, MS, at the 26th European Organisation for Research and Treatment of Cancer Symposium in Barcelona show "extremely promising" ...
Nov 25, 2014
0
0